Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: Vmn1r228 (vomeronasal 1 receptor 228) Mus musculus
Analyze
Symbol: Vmn1r228
Name: vomeronasal 1 receptor 228
CRRD ID: 1553467
Description: Predicted to have pheromone binding activity and pheromone receptor activity. Predicted to be involved in response to pheromone. Predicted to localize to integral component of plasma membrane. Orthologous to human VN1R2 (vomeronasal 1 receptor 2) and VN1R4 (vomeronasal 1 receptor 4); INTERACTS WITH folic acid.
Type: protein-coding
RefSeq Status: VALIDATED
Also known as: V1r; V1re3; Vldr1; vomernasal 1 receptor Vmn1r228; vomeronasal 1 receptor, E3; vomeronasal receptor 1 D1; vomeronasal type 1 receptor E3
Orthologs:
No known orthologs. homologs ...
Related Pseudogenes: Vmn1r-ps141  
Latest Assembly: GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391720,996,321 - 20,997,763 (-)NCBI
GRCm381720,776,059 - 20,777,501 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1720,774,984 - 20,786,157 (-)EnsemblGRCm38mm10GRCm38
MGSCv371720,913,023 - 20,914,465 (-)NCBIGRCm37mm9NCBIm37
MGSCv361720,480,756 - 20,482,198 (-)NCBImm8
Celera1721,808,604 - 21,810,046 (-)NCBICelera
Cytogenetic Map17A3.2NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations
Gene Ontology Annotations
References - curated
References - uncurated

Genomics

Position Markers
QTLs in Region (GRCm38)
miRNA Target Status

Expression


Sequence

Nucleotide Sequences
Protein Sequences

Additional Information

External Database Links
Nomenclature History
 
More on Vmn1r228
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: mm9 mm10
MGI Report
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1553467
Created: 2005-09-30
Species: Mus musculus
Last Modified: 2020-10-13
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.